Pancreatic Cancer Research

ResearcherEhime UniversityActive in the last 2 years

Yoshinori Ohno

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5058045855. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: 1 paper · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: 1 paper · 2023: 1 paper · 2024: none · 2025: 2 papers

Papers 9

  1. A multicenter prospective observational study for health assessment questionnaires EQ-5D-5L and G8 in unresectable advanced pancreatic cancer treated with firs… Co-author DOI 10.1007/s10147-025-02717-1↗
  2. Clinicopathological features for clinically resectable peripherally located pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.pan.2025.06.010↗
  3. Patients with Chronic Liver Disease under Surveillance for Hepatocellular Carcinoma Have a Favorable Long-Term Outcome for Pancreatic Cancer Due to Early Diagn… Co-author DOI 10.3390/cancers15030561↗
  4. Endoscopic duodenal stent placement versus gastrojejunostomy for unresectable pancreatic cancer patients with duodenal stenosis before introduction of initial … Co-author DOI 10.1093/jjco/hyab194↗
  5. Simple prognostic markers for optimal treatment of patients with unresectable pancreatic cancer. Co-author DOI 10.1097/md.0000000000027591↗
  6. ABO Blood Type and the Long-term Outcomes of Pancreatic Cancer. Co-author DOI 10.2169/internalmedicine.3748-19↗
  7. Early Detection of Pancreatic Cancer in Patients With Chronic Liver Disease Under Hepatocellular Carcinoma Surveillance. Co-author DOI 10.1016/j.mayocp.2018.12.034↗
  8. Efficacy of chemotherapy in elderly patients with unresectable pancreatic cancer: a multicenter review of 895 patients. Co-author DOI 10.1186/s12876-017-0623-8↗
  9. Improvement of long-term outcomes in pancreatic cancer and its associated factors within the gemcitabine era: a collaborative retrospective multicenter clinica… Co-author DOI 10.1186/1471-230x-13-134↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mitsuhito Koizumi · 8 shared papers, 2013–2025 · strength 0.95
  2. Yoichi Hiasa · 8 shared papers, 2013–2025 · strength 0.95
  3. Teru Kumagi · 7 shared papers, 2013–2025 · strength 0.70
  4. Taira Kuroda · 7 shared papers, 2013–2025 · strength 0.70
  5. Nobuaki Azemoto · 7 shared papers, 2013–2023 · strength 0.61
  6. Ichinosuke Hyodo · 3 shared papers, 2021–2025 · strength 0.56
  7. Akinori Asagi · 3 shared papers, 2022–2025 · strength 0.55
  8. Yoshinori Tanaka · 6 shared papers, 2013–2023 · strength 0.50
  9. Takashi Terao · 5 shared papers, 2017–2023 · strength 0.47
  10. Toru Otsuru · 2 shared papers, 2025 · strength 0.45
  11. Hiroshi Ishii · 3 shared papers, 2019–2022 · strength 0.27
  12. Kaori Hino · 1 shared paper, 2025 · strength 0.20
  13. Yuki Numata · 1 shared paper, 2025 · strength 0.20
  14. Masanori Abe · 2 shared papers, 2013–2020 · strength 0.11
  15. Akiko Tsujimoto · 1 shared paper, 2022 · strength 0.11
  16. Hiroaki Yanagimoto · 1 shared paper, 2022 · strength 0.11
  17. Kunihiro Tsuji · 1 shared paper, 2022 · strength 0.11
  18. Nobumasa Mizuno · 1 shared paper, 2022 · strength 0.11
  19. Yuya Hisada · 1 shared paper, 2022 · strength 0.11
  20. Masayuki Furukawa · 1 shared paper, 2022 · strength 0.11
  21. Satoshi Kobayashi · 1 shared paper, 2022 · strength 0.11
  22. Rei Suzuki · 1 shared paper, 2022 · strength 0.11
  23. Masafumi Ikeda · 1 shared paper, 2022 · strength 0.11
  24. Naohiro Okano · 1 shared paper, 2022 · strength 0.11
  25. Hiroki Sato · 1 shared paper, 2022 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.